Best of cannabinoid science this week...
In a fascinating study of autistic children, they looked at how biomarkers in the saliva could be used to measure the effectiveness of cannabis treatment
The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder
https://pubmed.ncbi.nlm.nih.gov/35343818/
In a case series of dementia patients, 15 days of CBD improved their symptoms Neuropsychiatric Symptoms in Dementia. The Added Value of Cannabinoids. Are they a Safe and Effective Choice? Case Series with Cannabidiol 3% https://www.researchgate.net/publication/359424583_Neuropsychiatric_Symptoms_in_Dementia_The_Added_Value_of_Cannabinoids_Are_they_a_Safe_and_Effective_Choice_Case_Series_with_Cannabidiol_3
A survey of multiple sclerosis patients found that two-thirds of them used cannabis to help alleviate symptoms
Medical cannabis use in Canadians with multiple sclerosis
https://pubmed.ncbi.nlm.nih.gov/35382939/
In an intriguingly designed Human Laboratory Study, CBD seems to ‘dial down’ the mental effects of THC relevant to psychosis
Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior
https://pubmed.ncbi.nlm.nih.gov/35319274/
Against two types of salmonella, CBD was as effective as ampicillin Cannabis sativa CBD Extract Shows Promising Antibacterial Activity against S. typhimurium and S. Newington https://www.preprints.org/manuscript/202203.0367/v1
In the fat tissue of rats, CBD enhanced the glucose uptake, improved glucose-lipid homeostasis & enhanced antioxidative activities Cannabidiol improves glucose utilization and modulates glucose-induced dysmetabolic activities in isolated rats' peripheral adipose tissues https://pubmed.ncbi.nlm.nih.gov/35358799/